Rezolute Inc.

Last updated September 27, 2026

Organization details

Legal name
Rezolute Inc.
Former names
AntriaBio, Inc. Fits My Style Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Nevada
Headquarters city
Redwood City
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
June
Ticker symbol
RZLT
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001509261
EIN
27-3440894

Board of directors

Chief executives

Nevan C. Elam · CEO
Dates unknown

Director election results

Annual meeting of November 19, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 3 other boards. 3 are in the same sector.

Network of Rezolute Inc.'s board connections Denali Therapeutics Inc. Denali Therapeutics In... Savara Inc. Savara Inc. Xeris Biopharma Holdings Inc. Xeris Biopharma Holdin... Erik Harris Erik Harris Nerissa Kreher Nerissa Kreher Nevan C. Elam Nevan C. Elam Rezolute Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$235,879
9 purchases by 5 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 21, 2026 Evans Daron Officer (CFO) Gift −16,000 — —
Oct 21, 2026 Evans Daron Officer (CFO) Gift +4,000 — —
Oct 21, 2026 Evans Daron Officer (CFO) Gift +4,000 — —
Sep 2, 2026 Karnawat Sunil Ratilal Officer (Chief Commercial Officer) Shares withheld for tax −2,267 $4.50 $10,202
Jul 2, 2026 Nevan C. Elam Director, Officer (CEO) Shares withheld for tax −8,004 $4.99 $39,940
Jul 2, 2026 Evans Daron Officer (CFO) Shares withheld for tax −3,062 $4.99 $15,279
Jul 2, 2026 ROBERTS BRIAN KENNETH Officer (Chief Medical Officer) Shares withheld for tax −3,062 $4.99 $15,279
Mar 30, 2026 Evans Daron Officer (CFO) Open-market purchase +10,000 $2.85 $28,500
Mar 2, 2026 ROBERTS BRIAN KENNETH Officer (Chief Medical Officer) Shares withheld for tax −11,439 $2.99 $34,203
Mar 2, 2026 Evans Daron Officer (CFO) Shares withheld for tax −11,438 $2.99 $34,200
Mar 2, 2026 Nevan C. Elam Director, Officer (CEO) Shares withheld for tax −27,618 $2.99 $82,578
Dec 16, 2025 Wladimir Hogenhuis Director Open-market purchase +5,650 $1.69 $9,549
Dec 16, 2025 ROBERTS BRIAN KENNETH Officer (Chief Medical Officer) Open-market purchase +28,000 $1.70 $47,600
Dec 15, 2025 Evans Daron Officer (CFO) Open-market purchase +40,000 $1.77 $70,800
Dec 15, 2025 Nevan C. Elam Director, Officer (CEO) Open-market purchase +32,000 $1.59 $50,880

Organizations in the same sector, closest in location and size first.

Questions about Rezolute Inc.

Who is the CEO of Rezolute Inc.?

Nevan C. Elam is Rezolute Inc.'s CEO.

How many directors are on Rezolute Inc.'s board?

Rezolute Inc.'s board has 7 directors: Erik Harris, Gil M. Labrucherie, Nerissa Kreher, Nevan C. Elam, Philippe Fauchet, Wladimir Hogenhuis and Young-Jin Kim.

Are Rezolute Inc. insiders buying or selling shares?

Over the last 12 months, Rezolute Inc. insiders bought $235,879 of shares in 9 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="rezolute-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.